1
|
LIU J, TANG C, XIA Y, BAI Q. [Recent progress of chromatographic techniques for antibody purification]. Se Pu 2024; 42:533-543. [PMID: 38845514 PMCID: PMC11165393 DOI: 10.3724/sp.j.1123.2023.12010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/07/2023] [Indexed: 06/12/2024] Open
Abstract
Antibody drugs are becoming increasingly popular in disease diagnosis, targeted therapy, and immunoprevention owing to their characteristics of high targeting ability, strong specificity, low toxicity, and mild side effects. The demand for antibody drugs is steadily increasing, and their production scale is expanding. Upstream cell culture technology has been greatly improved by the high-capacity production of monoclonal antibodies. However, the downstream purification of antibodies presents a bottleneck in the production process. Moreover, the purification cost of antibodies is extremely high, accounting for approximately 50%-80% of the total cost of antibody production. Chromatographic technology, given its selectivity and high separation efficiency, is the main method for antibody purification. This process usually involves three stages: antibody capture, intermediate purification, and polishing. Different chromatographic techniques, such as affinity chromatography, ion-exchange chromatography, hydrophobic interaction chromatography, mixed-mode chromatography, and temperature-responsive chromatography, are used in each stage. Affinity chromatography, mainly protein A affinity chromatography, is applied for the selective capture and purification of antibodies from raw biofluids or harvested cell culture supernatants. Other chromatographic techniques, such as ion-exchange chromatography, hydrophobic interaction chromatography, and mixed-mode chromatography, are used for intermediate purification and antibody polishing. Affinity biomimetic chromatography and hydrophobic charge-induction chromatography can produce antibodies with purities comparable with those obtained through protein A chromatography, by employing artificial chemical/short peptide ligands with good selectivity, high stability, and low cost. Temperature-responsive chromatography is a promising technique for the separation and purification of antibodies. In this technique, antibody capture and elution is controlled by simply adjusting the column temperature, which greatly eliminates the risk of antibody aggregation and inactivation under acidic elution conditions. The combination of different chromatographic methods to improve separation selectivity and achieve effective elution under mild conditions is another useful strategy to enhance the yield and quality of antibodies. This review provides an overview of recent advances in the field of antibody purification using chromatography and discusses future developments in this technology.
Collapse
|
2
|
van Schaick G, Pot S, Schouten O, den Hartog J, Akeroyd M, van der Hoeven R, Bijleveld W, Abello N, Wuhrer M, Olsthoorn M, Dominguez-Vega E. Evaluating the effect of glycation on lipase activity using boronate affinity chromatography and mass spectrometry. Food Chem 2023; 421:136147. [PMID: 37087987 DOI: 10.1016/j.foodchem.2023.136147] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/12/2022] [Revised: 03/07/2023] [Accepted: 04/10/2023] [Indexed: 05/03/2023]
Abstract
Protein glycation may occur naturally when reducing sugars and proteins coexist, which is often the case for industrial enzymes. The impact of post-translational modifications on enzyme performance (e.g., stability or function) is often not predictable, highlighting the importance of having appropriate analytical methodologies to monitor the influence of glycation on performance. Here, a boronate affinity chromatography method was developed to enrich glycated species followed by mass spectrometry for structural characterization and activity assays for functional assessment. This approach was applied to a (temperature-stressed) lipase used for food applications revealing that storage at -20 °C and 4 °C resulted in minor glycation (below 9%), whereas storage at 25 °C led to a higher glycation level with up to four sugars per lipase molecule. Remarkably, activity measurements revealed that glycation did not reduce lipase activity or stability. Altogether, this novel strategy is a helpful extension to the current analytical toolbox supporting development of enzyme products.
Collapse
Affiliation(s)
- Guusje van Schaick
- Leiden University Medical Center, Center for Proteomics and Metabolomics, Leiden, the Netherlands.
| | - Sanne Pot
- Leiden University Medical Center, Center for Proteomics and Metabolomics, Leiden, the Netherlands
| | - Olaf Schouten
- DSM Science & Innovation, Biodata & Translation, Center for Analytical Innovation, Delft, the Netherlands
| | - Joost den Hartog
- DSM Science & Innovation, Biodata & Translation, Center for Analytical Innovation, Delft, the Netherlands
| | - Michiel Akeroyd
- DSM Science & Innovation, Biodata & Translation, Center for Analytical Innovation, Delft, the Netherlands
| | - Rob van der Hoeven
- DSM Science & Innovation, Biodata & Translation, Center for Analytical Innovation, Delft, the Netherlands
| | - Wim Bijleveld
- DSM Science & Innovation, Biodata & Translation, Center for Analytical Innovation, Delft, the Netherlands
| | - Nicolas Abello
- DSM Science & Innovation, Biodata & Translation, Center for Analytical Innovation, Delft, the Netherlands
| | - Manfred Wuhrer
- Leiden University Medical Center, Center for Proteomics and Metabolomics, Leiden, the Netherlands
| | - Maurien Olsthoorn
- DSM Science & Innovation, Biodata & Translation, Center for Analytical Innovation, Delft, the Netherlands
| | - Elena Dominguez-Vega
- Leiden University Medical Center, Center for Proteomics and Metabolomics, Leiden, the Netherlands
| |
Collapse
|
3
|
Emerging affinity ligands and support materials for the enrichment of monoclonal antibodies. Trends Analyt Chem 2022. [DOI: 10.1016/j.trac.2022.116744] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
|
4
|
Pappenreiter M, Lhota G, Vorauer‐Uhl K, Sissolak B. Antibody glycation during a
CHO
fed‐batch process following a constrained second order reaction. Biotechnol Prog 2022; 38:e3261. [DOI: 10.1002/btpr.3261] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2021] [Revised: 03/28/2022] [Accepted: 04/13/2022] [Indexed: 11/08/2022]
Affiliation(s)
- Magdalena Pappenreiter
- Innovation Management Bilfinger Life Science GmbH Salzburg Austria
- Institute of Bioprocess Science and Engineering, Department of Biotechnology University of Natural Resources and Life Sciences Vienna Austria
| | - Gabriele Lhota
- Institute of Bioprocess Science and Engineering, Department of Biotechnology University of Natural Resources and Life Sciences Vienna Austria
| | - Karola Vorauer‐Uhl
- Institute of Bioprocess Science and Engineering, Department of Biotechnology University of Natural Resources and Life Sciences Vienna Austria
| | | |
Collapse
|
5
|
van Schaick G, el Hajjouti N, Nicolardi S, den Hartog J, Jansen R, van der Hoeven R, Bijleveld W, Abello N, Wuhrer M, Olsthoorn MMA, Domínguez-Vega E. Native Liquid Chromatography and Mass Spectrometry to Structurally and Functionally Characterize Endo-Xylanase Proteoforms. Int J Mol Sci 2022; 23:1307. [PMID: 35163230 PMCID: PMC8835838 DOI: 10.3390/ijms23031307] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/24/2021] [Revised: 01/17/2022] [Accepted: 01/21/2022] [Indexed: 12/16/2022] Open
Abstract
Xylanases are of great value in various industries, including paper, food, and biorefinery. Due to their biotechnological production, these enzymes can contain a variety of post-translational modifications, which may have a profound effect on protein function. Understanding the structure-function relationship can guide the development of products with optimal performance. We have developed a workflow for the structural and functional characterization of an endo-1,4-β-xylanase (ENDO-I) produced by Aspergillus niger with and without applying thermal stress. This workflow relies on orthogonal native separation techniques to resolve proteoforms. Mass spectrometry and activity assays of separated proteoforms permitted the establishment of structure-function relationships. The separation conditions were focus on balancing efficient separation and protein functionality. We employed size exclusion chromatography (SEC) to separate ENDO-I from other co-expressed proteins. Charge variants were investigated with ion exchange chromatography (IEX) and revealed the presence of low abundant glycated variants in the temperature-stressed material. To obtain better insights into the effect on glycation on function, we enriched for these species using boronate affinity chromatography (BAC). The activity measurements showed lower activity of glycated species compared to the non-modified enzyme. Altogether, this workflow allowed in-depth structural and functional characterization of ENDO-I proteoforms.
Collapse
Affiliation(s)
- Guusje van Schaick
- Center for Proteomics and Metabolomics, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands; (N.e.H.); (S.N.); (M.W.); (E.D.-V.)
| | - Nadi el Hajjouti
- Center for Proteomics and Metabolomics, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands; (N.e.H.); (S.N.); (M.W.); (E.D.-V.)
| | - Simone Nicolardi
- Center for Proteomics and Metabolomics, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands; (N.e.H.); (S.N.); (M.W.); (E.D.-V.)
| | - Joost den Hartog
- Center for Analytical Innovation, DSM, Alexander Fleminglaan 1, 2613 AX Delft, The Netherlands; (J.d.H.); (R.J.); (R.v.d.H.); (W.B.); (N.A.); (M.M.A.O.)
| | - Romana Jansen
- Center for Analytical Innovation, DSM, Alexander Fleminglaan 1, 2613 AX Delft, The Netherlands; (J.d.H.); (R.J.); (R.v.d.H.); (W.B.); (N.A.); (M.M.A.O.)
| | - Rob van der Hoeven
- Center for Analytical Innovation, DSM, Alexander Fleminglaan 1, 2613 AX Delft, The Netherlands; (J.d.H.); (R.J.); (R.v.d.H.); (W.B.); (N.A.); (M.M.A.O.)
| | - Wim Bijleveld
- Center for Analytical Innovation, DSM, Alexander Fleminglaan 1, 2613 AX Delft, The Netherlands; (J.d.H.); (R.J.); (R.v.d.H.); (W.B.); (N.A.); (M.M.A.O.)
| | - Nicolas Abello
- Center for Analytical Innovation, DSM, Alexander Fleminglaan 1, 2613 AX Delft, The Netherlands; (J.d.H.); (R.J.); (R.v.d.H.); (W.B.); (N.A.); (M.M.A.O.)
| | - Manfred Wuhrer
- Center for Proteomics and Metabolomics, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands; (N.e.H.); (S.N.); (M.W.); (E.D.-V.)
| | - Maurien M. A. Olsthoorn
- Center for Analytical Innovation, DSM, Alexander Fleminglaan 1, 2613 AX Delft, The Netherlands; (J.d.H.); (R.J.); (R.v.d.H.); (W.B.); (N.A.); (M.M.A.O.)
| | - Elena Domínguez-Vega
- Center for Proteomics and Metabolomics, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands; (N.e.H.); (S.N.); (M.W.); (E.D.-V.)
| |
Collapse
|
6
|
Lhota G, Sissolak B, Striedner G, Sommeregger W, Vorauer-Uhl K. Quantification of glycated IgG in CHO supernatants: A practical approach. Biotechnol Prog 2021; 37:e3124. [PMID: 33428326 PMCID: PMC8365726 DOI: 10.1002/btpr.3124] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/19/2020] [Revised: 12/09/2020] [Accepted: 12/20/2020] [Indexed: 01/26/2023]
Abstract
Post-translational, nonenzymatic glycation of monoclonal antibodies (mAbs) in the presence of reducing sugars (in bioprocesses) is a widely known phenomenon, which affects protein heterogeneity and potentially has an impact on quality, safety, and efficacy of the end product. Quantification of individual glycation levels is compulsory for each mAb therapeutically applied in humans. We therefore propose an analytical method for monitoring glycation levels of mAb products during the bioprocess. This is a useful tool for process-design considerations, especially concerning glucose-feed strategies and temperature as major driving factors of protein glycation. In this study, boronate affinity chromatography (BAC) was optimized for determination of the glycation level of mAbs in supernatants. In fact, the complex matrix found in supernatants is an underlying obstacle to use BAC, but with a simple clean-up step, we found that the elution profile could be significantly improved so that qualitative and quantitative determination could be reached. Complementary analytical methods confirmed the performance quality, including the correctness and specificity of the results. For quantitative determination of mAb glycation in supernatants, we established a calibration procedure for the retained mAb peak, identified as glycated antibody monomers. For this approach, an available fully characterized mAb standard, Humira®, was successfully applied, and continuous monitoring of mAbs across three repetitive fed-batch processes was finally performed. With this practical, novel approach, an insight was obtained into glycation levels during bioprocessing, in conjunction with glucose levels and product titer over time, facilitating efficient process development and batch-consistency monitoring.
Collapse
Affiliation(s)
- Gabriele Lhota
- Institute of Bioprocess Science and Engineering, Department of Biotechnology, University of Natural Resources and Life Sciences, Vienna, Austria
| | - Bernhard Sissolak
- Research and Development, Bilfinger Industrietechnik Salzburg GmbH, Salzburg, Austria
| | - Gerald Striedner
- Institute of Bioprocess Science and Engineering, Department of Biotechnology, University of Natural Resources and Life Sciences, Vienna, Austria
| | - Wolfgang Sommeregger
- Research and Development, Bilfinger Industrietechnik Salzburg GmbH, Salzburg, Austria
| | - Karola Vorauer-Uhl
- Institute of Bioprocess Science and Engineering, Department of Biotechnology, University of Natural Resources and Life Sciences, Vienna, Austria
| |
Collapse
|